Sarcopenia in ICU patients on long-term ventilation
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study checks for muscle loss (sarcopenia) in ICU patients who need a breathing machine (mechanical ventilation). It aims to track how muscle health changes during hospital stay.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be 18 years or older.
- Expected to need a breathing machine (mechanical ventilation) for more than 48 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how loss of muscle mass (sarcopenia) affects the course of illness in people with gastrointestinal cancers, liver cirrhosis, or those in the ICU. It will help doctors better understand and treat muscle wasting.
This study looks at how the diaphragm (a key breathing muscle) changes during and after being on a breathing machine in the ICU. It may help researchers understand why breathing can get weaker after ventilation and how to measure it safely (including with MRI).
This trial uses ultrasound to measure the thickness of a neck muscle to see how it relates to muscle loss (sarcopenia) in people in intensive care. It may help researchers find simple ways to spot and track muscle decline during an ICU stay.
This study looks at how quickly older adults lose muscle strength and mass while hospitalized for a sudden medical illness. It may help find ways to prevent or treat this muscle loss.
This study uses ultrasound to check the muscles that help you swallow and move. It aims to see if measuring these muscles can predict swallowing problems and muscle loss after being on a breathing machine.
This trial looks at how to improve muscle strength and function after a stay in the ICU for sepsis or acute respiratory failure. If you recover from the illness but your muscles become weak, this study may test an approach to help rebuild strength faster.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.